These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6108127)

  • 1. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.
    Warrington SJ; Turner P; Kilborn JR; Bianchetti G; Morselli PL
    Br J Clin Pharmacol; 1980 Nov; 10(5):449-52. PubMed ID: 6108127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
    Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
    Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of betaxolol on heart rate at rest and during exercise.
    Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
    Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects.
    Ludden TM; Boyle DA; Gieseker D; Kennedy GT; Crawford MH; Ludden LK; Clementi WA
    J Pharm Sci; 1988 Sep; 77(9):779-83. PubMed ID: 2906367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.
    Beresford R; Heel RC
    Drugs; 1986 Jan; 31(1):6-28. PubMed ID: 2866947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT.
    Radice M; Amanzio R; Criscuolo D
    Eur J Clin Pharmacol; 1979 Sep; 16(2):87-90. PubMed ID: 40801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G; Thiercelin JF; Thenot JP
    Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of effect of SL75212 on an exercise tachycardia [proceedings].
    Balnave K; Neill JD; Russell CJ; Shanks RG; Leahey WJ; Wilson R; Harran DW
    Br J Clin Pharmacol; 1980 Mar; 9(3):297P-298P. PubMed ID: 6102471
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.